Combination therapy for treatment of female breast cancer

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3724

Patent

active

046668853

ABSTRACT:
A method of treatment of breast cancer in susceptible animals whose ovarian hormonal secretions are blocked by surgical or chemical means, e.g., by use of an LH-RH agonist, e.g., [D-Trp.sup.6, des-Gly-NH.sub.2.sup.10 ]LH-RH ethylamide with a therapy comprising administering an antiandrogen, e.g., flutamide and an optionally, an inhibitor of adrenal sex steroid biosynthesis e.g., aminoglutethimide, pharmaceutical compositions useful for such treatment and two, four and five component pharmaceutical kits containing such compositions are disclosed.

REFERENCES:
patent: 4024248 (1977-05-01), Konig et al.
patent: 4071622 (1978-01-01), Johnson et al.
patent: 4094994 (1979-06-01), Schonenberger et al.
patent: 4097578 (1978-06-01), Perronnet et al.
patent: 4100274 (1978-07-01), Dutta et al.
patent: 4118483 (1978-10-01), Konig et al.
patent: 4239776 (1980-12-01), Glen et al.
patent: 4329364 (1982-05-01), Neri et al.
patent: 4386080 (1983-05-01), Crowley et al.
patent: 4472382 (1984-09-01), Labrie et al.
patent: 4481190 (1984-11-01), Nestor et al.
Cancer Research 42, 4788-4791 (1982).
J. Steroid Biochem., vol. 19, No. 1, pp. 999-1007 (1983).
J. of Steroid Biochem., vol. 14, pp. 819-822 (1981).
Nature, vol. 313 (1985), pp. 231-233.
Cancer Treatment Reports, vol. 68 (No. 1), pp. 281-289 (1984), A. V. Schally et al.
Proc. Natl. Acad. Sci. USA, vol. 80, pp. 1459-1462 (1983), T. W. Redding and A. V. Schally.
"LH-RH Analogs in the Treatment of Human Breast Cancer", H. A. Harvey et al., in LHRH and Its Analogs-A New Class of Contraceptive and Therapewtic Agents, pp. 329-335, (B. H. Vickery et al. etc.) MTP Press Lancaster VIC/1192.
Doll, R., et al., Cancer Incidence in Five Continents, II Springer-Verlag, (UICC Publications, New York) 1970.
Wang, D. Y. et al., Europ. J. Cancer (1976) vol. 12, pp. 951-958.
Adams, J. B., Cancer (1977), vol. 40, pp. 325-333.
Wong, D. Y., et al., Europ. J. Cancer (1975), vol. 11, pp. 873-879.
Secreto, G., et al., Europ. J. Cancer. Clin. Oncol. (1983), vol. 19, pp. 5-10.
F. Labrie et al., "Inhibition of Testicular and Ovarian Functions by LHRH Agonists," In: Bioregulators of Reproduction, (1982) Academic Press, pp. 305-341.
Meldrum, D. R., et al., J. Clin. Endocrinol. Metab., (1982), vol. 54, pp. 1081-1083.
Nicholson, R. I., et al. Reviews in Endocrine-Related Cancer (1984), Nicholson, R. I. and Griffins, K., eds).
Klijn, J. G. and De Jong, F. H., The Lancet (1982), pp. 1213-1216.
J. Steroid Biochem., vol. 20 (No. 6B) 1381 (1984), J. G. M. Klijn et al.
J. Med. Chem., vol. 21 1018-1024 (1978), A. S. Dutta et al.
Biochem. Biophy. Res. Commun., vol. 100, pp. 915-920 (1981) J. Erchegg, et al.
Endrocrinology, vol. 110, pp. 1445-1447 (1982); D. H. Coy et al.
J. Steroid. Biochem., vol. 20 (No. 6B), 1366 (1984); J. J. Nestor et al.
J. Steroid Biochem., vol. 20, (No. 6B) 1365 (1984); J. Rivier et al.
J. Steroid Biochem., vol. 20 (No. 6B) p. 1369 (1984); A. Corbin et al.
LH-RH and Its Analogs (B. H. Vickery et al. Editors), pp. 3-10, J. J. Nestor.
LH-RH and Its Analogs (B. H. Vickery et al. Editors), pp. 11-22, J. Rivier et al.
LH-RH and Its Analogs (B. H. Vickery et al. Editors) pp. 23-33, J. J. Nestor et al.
"Solid Phase Peptide Synthesis", Stewart et al. Freman and Co., San Francisco, CA. (1969), pp. 1-26.
J. Med. Chem., vol. 19, pp. 423-425 (1976) D. H. Coy et al.
Trams, G. and Maass, S. H., Cancer Res. (1977), vol. 37, pp. 258-261.
Flax, H. et al., The Lancet (1973) pp. 1204-1207.
Wagner, R. K. and Jungblut, P. W., Acta Endocrinologica (1976), vol. 82, pp. 105-120.
Matsumoto, K. et al. Hormonal Regulators of Mammary Tumors (1984), B. S. Leung ed.; Eden Press, Inc. (1984), pp. 216-244.
Lancet, 1, 1213-1216 (1982), J. G. M. Klijn et al., (The Lancet, May 29, 1982).
Cancer, vol. 50, 1708-1712 (1982), A. V. Buzdar et al.
Lancet, 1204-1207 (1973), H. Flax et al. (The Lancet; Jun. 2, 1973).
The Prostate, vol. 4, 579-594 (1983), F. Labrie et al.
Cancer Treatment Review, vol. 5, 131-141 (1978), H. Movridsen et al.
J. L. Hayward et al., Cancer (Mar. 1977), vol. 39, pp. 1289-1294.
C. Huggins et al., Ann. Surg. (1945), vol. 122, pp. 1031-1041.
C. Huggins et al., JAMA (1951), vol. 147, pp. 101-1-6.
A. A. Fracchia et al., Surg. Gynecol. Obstet (1967), vol. 125, pp. 747-756.
H. S. Harris et al., Cancer (1969), vol. 24, pp. 145-151.
Brown, P. W., et al., Arch. Surg. (1975), vol. 110, pp. 77-81.
Silverstein, M. J. et al., Surgery, (1975), vol. 77, pp. 825-832.
Smith, I. E., et al., Brit. Med. J. (1981), vol. 283, pp. 1432-1434.
Buzdar, A. V. et al., Cancer (1982), vol. 50, pp. 1708-1712.
Santen, R. J., et al., New. Engl. J. Med., (1981), vol. 305, pp. 545-551.
Seymour-Munn, K. and Adams, J., Endocrinology (1983), vol. 112, pp. 486-491.
Reed, M. J. et al., Cancer Research (1983), vol. 43, pp. 3940-3943.
Labrie, F. et al., Raven Press, (in press), J. G. M. Kijn, ed.
Seqi, M., et al. Sendai, Tokoku University School of Medicine (1969).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Combination therapy for treatment of female breast cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy for treatment of female breast cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy for treatment of female breast cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1564917

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.